Medical Oxygen Supply: Meeting ICU Demand Across East Africa

The Challenge: ICU Oxygen Demand in East Africa

In early 2024, a group of hospitals across Tanzania and Kenya faced a recurring problem: their medical oxygen supply was unreliable. Liquid oxygen deliveries were inconsistent, cylinder refill turnaround times stretched past predictable limits, and during seasonal peaks in respiratory admissions, clinical teams were forced to ration oxygen between patients. The hospitals operated ICU and high-dependency beds that could not function at full capacity because the oxygen supply chain could not keep pace with clinical demand.

Oxygen is a treatment, not just a consumable. A patient with severe pneumonia, a post-surgical complication, or a trauma injury requires a continuous, uninterrupted flow of oxygen at a prescribed concentration. When that flow is interrupted because a cylinder is empty and the replacement has not arrived, the clinical consequences are immediate and severe. The hospitals needed a solution that would give them control over their own oxygen supply, rather than depending on deliveries from centralized filling plants located hours away.

Our Approach: Sourcing and Logistics Planning

4iTrading was asked to source pressure swing adsorption oxygen generation plants, commonly called PSA plants, capable of producing medical-grade oxygen at each hospital site. PSA technology separates oxygen from ambient air using molecular sieves, producing a continuous supply at 93 to 95 percent purity, which meets pharmacopoeia standards for medical oxygen. The key advantage of PSA plants over cylinder-based supply is independence: once installed and commissioned, the hospital produces its own oxygen on demand, eliminating the logistics chain that had been the source of previous failures.

We evaluated manufacturers across three continents, applying the same quality criteria we use for all medical equipment partners: ISO 13485 certification, CE marking for the complete system including compressor and filtration stages, documented installation references at hospitals in comparable climates, and availability of remote technical support. The selected manufacturer had prior installations in South Asia and the Middle East operating in ambient temperatures exceeding 35 degrees Celsius, which matched the conditions these East African hospitals would present.

Execution: Installation, Commissioning, and Training

The equipment was shipped from the manufacturer's facility to Dar es Salaam and Mombasa via consolidated sea freight, with each plant broken down into modules that could be transported by truck to the hospital sites. Site preparation, including concrete pads, electrical supply, and piping infrastructure, was completed by local contractors during the transit window. This parallel workstream reduced the total project timeline by keeping site readiness and equipment logistics moving simultaneously.

Commissioning took place over a two-week period at each site. The manufacturer's engineer worked alongside hospital maintenance staff, conducting installation verification, purity testing across the full output range, and failover testing to confirm that backup cylinder manifolds would activate automatically if the PSA plant went offline. We used this commissioning window as a training opportunity: hospital biomedical engineers and maintenance technicians participated in every test and calibration, building the in-house competence needed to operate and maintain the equipment independently after the manufacturer's team departed.

Results: Hospitals Served and Impact Delivered

By mid-2025, three hospitals were operating their own PSA oxygen plants, producing medical oxygen at a per-cubic-meter cost significantly below the previous cylinder delivery model. ICU bed availability increased because oxygen supply was no longer a constraint on admissions. The hospitals also gained the ability to supply oxygen to their operating theatres, neonatal units, and emergency departments at consistent pressure and purity, something that had been inconsistent under the cylinder-based model.

Beyond the clinical impact, the hospitals achieved operational savings that allowed them to redirect budget toward other critical needs. The PSA plants are designed for a service life exceeding ten years with routine maintenance, creating a durable solution rather than a stopgap. For 4iTrading, the project demonstrated the value of approaching medical equipment supply as a project development exercise, not a transaction. Sourcing the right equipment was important, but coordinating site preparation, logistics, commissioning, and training was equally important to the outcome.

A reliable oxygen supply is not a procurement problem. It is an infrastructure problem. Solving it requires equipment, logistics, site engineering, and training, delivered as a coordinated project rather than a series of separate purchases.